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ABSTRACT

Most of the chronic diseases have a well-known natural staging system through which the
disease progression is interpreted. It is well established that the transition rates from one stage of
disease to other stage can be modeled by multi state Markov models. But, it is also well known
that the screening systems used to diagnose disease states may subject to error some times. In
this study, a simulation study is conducted to illustrate the importance of addressing for
misclassification in multi-state Markov models by evaluating and comparing the estimates for
the disease progression Markov model with misclassification opposed to disease progression
Markov model. Results of simulation study support that models not accounting for possible
misclassification leads to bias. In order to illustrate method of accounting for misclassification is
illustrated using dementia data which was staged as no cognitive impairment, mild cognitive
impairment and dementia and diagnosis of dementia stage is prone to error sometimes. Subjects
entered the study irrespective of their state of disease and were followed for one year and their
disease state at follow up visit was recorded. This data is used to illustrate that application of
multi state Markov model which is an example of Hidden Markov model in accounting for
misclassification which is based on an assumption that the observed (misclassified) states
conditionally depend on the underlying true disease states which follow the Markov process. The
misclassification probabilities for all the allowed disease transitions were also estimated. The
impact of misclassification on the effect of covariates is estimated by comparing the hazard
ratios estimated by fitting data with progression multi state model and by fitting data with multi
iv

state model with misclassification which revealed that if misclassification has not been addressed
the results are biased. Results suggest that the gene apoe ε4 is significantly associated with
disease progression from mild cognitive impairment to dementia but, this effect was masked
when general multi state Markov model was used. While there is no significant relation is found
for other transitions.
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CHAPTER ONE:
INTRODUCTION

Understanding a disease by its uniquely characterized progression of symptoms and
pathology plays vital role in correct diagnosis and suitable treatment plan. If a disease can be
diagnosed or detected at an early state, it may be more responsive to treatment. An effective
method to reduce mortality due to the disease can be effectively reduced by a systematic
screening of population. A detailed knowledge of the natural history of a disease is very essential
in order to develop and establish a systematic screening policy. The risk of onset of disease can
be used to determine the type of population and time of population to screen but to determine the
intervals between successive screens should be chosen based on the risk of progression. The risk
of progression may vary with current stage of disease. Multistate Markov models can be
effectively used to determine the course of a disease. (Jackson et al, 2003)
These models are very useful in estimating the transition rates between each disease state
and simultaneously estimate the misclassification probabilities and also to understand the effect
of covariates on transitions of disease states. (Andersen and Keiding, 2002; Commenges, 1999)
Examples of application of multi-state models in medicine are liver cirrhosis (Anderson et al.,
1991), screening for abdominal aortic aneurysm (Jackson et al., 2011), smoking prevention
(Kalbfleisch and lawless, 1985; Chen et al., 2011), psoriatic arthritis (Chen et al., 2010; Cook et
al., 2004, Sutradhar and Cook, 2008), screening of breast cancer (Duffy et al., 1995; Chen et al.,
1

1996,2000), chronic myelogenous leukemia (Klein et al., 1984), diabetic complications (
Kosorok and Chao, 1996; Marshall and Jones, 1995; Anderson, 1988), complications after heart
transplantation (Sharples, 1993; Klotz and Sharples, 1994), Aquired immune deficiency
syndrome and Human immunodeficiency virus infection (Longini et al., 1989; Gentleman et al.,
1994; Satten and Longini, 1996; Guihenneuc-Jouyaux et al., 2000; Alioum et al., 2005), hepatitis
C virus (Sweeting et al., 2010), human papillomavirus (Bureau et al., 2003; Kang and
Lagakos,2007), hepatocellular carcinoma (kay, 1986) and bronchiolitis obliteron after lung
transplantation (Jackson and Sharples, 2002).
The multi-state Markov models are characterized by Markov property which states that
distribution of forth coming state can be determined by the current state of disease. (The msm
package, version 0.6.4) More details of multi state Markov model is described in the subsequent
sections. For the multi-state Markov model to determine the course of the disease, the current
stage of disease should be determined without errors. But it is well known that any screening
method or diagnostic methods are prone to errors which might lead to misclassification of the
disease state. It is well established that misclassification of the outcome leads to bias in the
estimates. Even though, similar effects are expected to be observed with misclassification of
intermittent stages of disease, there are no sufficient studies reported to support the expectation
that misclassification of the intermittent stages in a multi-state model leads to bias.
In this study, illustration of application of multi-state model with misclassification in
screening of dementia is performed and simulation is used to prove that misclassification of the
intermittent disease states in a multi-state model when misclassification is not addressed leads to
bias of estimates. In order to account for the misclassification, multi-state model with
misclassification is fit to the data and the misclassification probabilities are estimated and impact
2

of misclassification on the effect of covariates on the transitions is estimated to fill the space in
the research addressing misclassification issues in multi-state models. In this study, data from
subjects at different stages of dementia (brief description of dementia and stages of dementia is
given under dementia section) is used to illustrate the effect of misclassification shown by
simulation study and portray the method of correcting the misclassification by fitting the data
with multi state Markov model without accounting for misclassification initially and then,
determine the misclassification probabilities by fitting multi state Markov model with
misclassification which enables to visualize the effect of accounting for misclassification
compared to not accounting for misclassification.

3

CHAPTER TWO:
TESTING A PROPORTION IN AN ENVIRONMENT OF MISCLASSIFICATION

A Brief Review

Before introducing the misclassification issue in a complex multi-state model, a brief
introduction about how error rate is addressed to test for a proportion in a misclassification
environment is depicted in this section. In a binomial experiment, to estimate a population
proportion ‘p’ from a large homogenous population and through random sampling, the sample
proportion is a sufficient statistic, is the maximum likelihood estimator and minimum variance
unbiased estimator of the population proportion ‘p’ in the absence of misclassification. But, in
reality errors happen. The diagnostic or screening methods or surveys are subject to errors and
there are many reasons explaining them and errors are inevitable during data collection. Making
inferences using such data can be inimical. (Bradley & Farnsworth, 2013; Rohatgi, 2003; Hogg
et al., 2005)

Error Rates in a Binomial Experiment

Let ‘T’ represent the true disease state of the subject and T=0 if subject is disease free
and T=1 if subject has the disease. ‘p’ represents the proportion of subjects who have the disease
4

and is given by the probability 𝑝 = Pr(𝑇 = 1). Let ‘O’ represent the observed disease state by
the screening test and O=1 for disease and O=0 for no disease. 𝑟 = Pr(𝑂 = 1)is the probability
of subject testing positive for disease. Thus, the false positive rate is given by 𝑟1 = Pr(𝑂 =
1| 𝑇 = 0) and false negative rate is given by 𝑟2 = Pr(𝑂 = 0| 𝑇 = 1) Therefore, r can be written
as

𝑟 = Pr(𝑂 = 1)
= Pr(𝑂 = 1| 𝑇 = 0)Pr(𝑇 = 0) +  Pr(𝑂 = 1| 𝑇 = 1)Pr(𝑇 = 0)
= 𝑟1 ∗ (1 − p) + (1 − 𝑟2 ) ∗ p
𝑟 = p(1 − 𝑟1 − 𝑟2 ) +  𝑟1

(1)

Probabilities 𝑝 and 𝑟 are linearly related for 𝑟1and𝑟2 .

1 − 𝑟1 − 𝑟2 > 0

(2)

The above equation of inequality ensures that ‘r’ increases with increasing ‘p’ and ‘r’ decreases
with

decreasing

‘p’

and

𝑟>0 .

Given

that

𝑟1 and 𝑟2

are

error

rates,

if

1−𝑟1 − 𝑟2 > 0, then the identifications of disease and no disease state are interchanged so that
equation (2) is satisfied. (Bradley & Farnsworth, 2013; Rohatgi, 2003; Hogg et al., 2005) For
example if p=0.30, 𝑟1 = 0.01 and 𝑟2 = 0.10 gives 𝑟 = 0.277 which is less than ‘p’ the true
proportion, if 𝑟1 = 0.02 and 𝑟2 = 0.08 gives 𝑟 = 0.3 which is equal to ‘p’ and if, 𝑟1 = 0.10 and
𝑟2 = 0.01 gives 𝑟 = 0.367 which is greater than ‘p’. Thus, based on the error rates, the estimated
proportions are biased from the true proportion accordingly.
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CHAPTER THREE:
ADDRESSING MISCLASSIFICATION USING MULTI STATE MARKOV MODELS

A Brief Introduction of Multi State Markov Models

Markov chains represent a class of stochastic processes of great interest for the wide
spectrum of practical applications. The course of disease is modeled often using multi state
models in continuous time. A general example that illustrates multi state Markov model is shown
in (Figure 1). (Jackson et al., 2003; the msm package, version 0.6.4)

Figure 1 Multi state model (General form)
The possible transitions between each disease state are represented by direction of arrow
marks. The disease state Si (t) is observed for each individual 𝑖 during arbitrary times𝑡 and it
6

may not be same for each individual. The disease state to which the individual moves and the
time of change will be determined by the transition intensity for each pair of states m & n. The
instantaneous risk of moving from stage ‘m’ to ‘n’ can be represented by the transition intensity.
The transition intensity matrix needs to be estimated in order to fit a multi-state model to the data
and for the general multi state model in (Figure 1) the transition intensity matrix Q takes the
form as

𝑞11
𝑞21
𝑄 =  (𝑞
31
𝑞41

𝑞12 𝑞13
𝑞22 𝑞23
𝑞32 𝑞33
𝑞42 𝑞43

𝑞14
𝑞24
𝑞34 )
𝑞44

The matrix Q represents these transition intensities whose rows sum to zero, so that the
diagonal entries are given by (equation 3). (Jackson et al., 2003; the msm package, version 0.6.4)

𝑞𝑚𝑚 =  − ∑𝑛≠𝑚 𝑞𝑚𝑛

(3)

The disease progression model which is used in this study is different from the general
multi state model in terms of possible transitions and depicted in (figure 2), where a series of
successive states of disease ending with an absorbing stage (death) is represented.
The subject is expected to progress to adjacent stage or recover to the previous stage or
move to absorbing stage (die) at any state of disease. (Jackson et al., 2003) Though, the model
used in this study does not contain an absorbing state as subjects who died at any stage of disease
were not included into the study.
7

Figure 2 Disease progression model (General form representing k states)

In order to calculate the likelihood for multi-state models, transition probability matrix
(Pt) is required. Transition probability is the probability of transition of disease from stage 𝑚 at
time 𝑐 to stage 𝑛 at time 𝑡 + 𝑐 and is given by (equation 4).

𝑝𝑚𝑛 (𝑡) = Pr(𝑆𝑖 (𝑡 + 𝑐) = 𝑛|𝑆𝑖 (𝑐) = 𝑚

𝑃(𝑡) = e(tQ) 

(4)

(5)

The information regarding the time of transition from state 𝑚 to 𝑛 is not given and the sampling
times are assumed to be non-informative. P (t) can be determined from scaled transition intensity
matrix by taking matrix exponential (equation 5). (Cox and Miller, 1965)
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Hidden Markov Model

This study involves illustration of methodology involved in addressing for
misclassification using multi state Markov model with misclassification which works with the
principle of Hidden Markov model (HMM). There are two process in hidden Markov model, the
observed process (𝑆(𝑡𝑖 )) and the true underlying process(𝑆 ∗ (𝑡𝑖 )). The true states of Markov
model are not observed in a hidden Markov model (HMM). Observed states (𝑆(𝑡𝑖 )) of HMM is
expected to be governed by emission distribution conditionally on underlying true states (𝑆 ∗ (𝑡𝑖 ))
(Figure 3). The underlying states of Markov chain are determined based on the transition
intensity matrix Q. In Hidden Markov models, observations were evolved based on unknown
distributions, thus HMM are mixture models but based on the states in HMM the distribution
involved changes with time. Hidden Markov models are the best option for studies involving
population with chronic disease with definite interpretation of stages. (The msm package, version
0.6.4, Jackson et al., 2003).

Figure 3 : Depicting observed and unobserved states at three time points

9

The above figure indicates that the conditional distribution of (𝑆 ∗ (𝑡2 )) is determined only
by the previous state(𝑆 ∗ (𝑡1 )). Similarly, the conditional distribution of (𝑆(𝑡2 )) given all the
process (𝑆 ∗ (𝑡1 )), (𝑆 ∗ (𝑡2 )), (𝑆 ∗ (𝑡3 )) and(𝑆(𝑡1 )), (𝑆(𝑡3 )) , it is determined only by the current
underlying state(𝑆 ∗ (𝑡2 )).

Multi State Models with Misclassification

Multi state model with misclassification is a type of Hidden Markov model where
observed states are expected to be misclassified. Here the observed data are states, assumed to be
misclassifications of the true, underlying states. The screening process or the diagnostic method
used to identify disease state may subject to error at times. In such situation the true Markov
disease process (𝑆 ∗ 𝑖 (𝑡)) for an individual ‘i’ can only be observed through realizations (𝑆𝑖 (𝑡))
and cannot be observed directly. Thus, the quality of a screening test or diagnostic test can be
determined by the probability that the observed disease state and the true underlying states are
equal. (The msm package, version 0.6.4)

Pr(Si (t) = m|S ∗ i (t) = m)

(6)

The sensitivity of the test or the probability that the test is a true positive is represented
by the above equation when m is a positive disease state. If m is a disease free state, then the
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above equation represents specificity, the probability that the diagnostic test truly identifies
disease free subjects. (The msm package, version 0.6.4)
In this study, multi-state model with misclassification is fit to the dementia data in order
to simultaneously determine the misclassification probabilities and also address for
misclassification in estimating the parameters. The observed disease states 𝑆𝑖𝑗 for subject i, at
observation time 𝑡𝑖𝑗 will be determined conditionally on the true underlying states 𝑆 ∗ 𝑖𝑗 based on
misclassification matrix E, where (m, n) entries are given by (equation 7)

𝑒𝑚𝑛 = Pr(𝑆(𝑡𝑖𝑗 ) = 𝑛|𝑆 ∗ (𝑡𝑖𝑗 ) = 𝑚

(7)

Based on the knowledge of the screening or diagnosis process some of the 𝑒𝑟𝑠 might be
fixed which is analogous to the entries of Q matrix. The misclassification matrix E governs the
observed process of the underlying states.

In this study, multi-state model is fit to dementia data to determine if addressing
misclassification has impact on the effect of covariates on disease progression or regression. In
order to develop a suitable multi state model that fit’s the data, the natural history of dementia
and its screening methods should be understood which is briefly explained in next subsection.
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Misclassification Probabilities using MSM

The unique feature about Multi State Modeling is that the misclassification probabilities
for transitions from one state to another can be determined when a multi-state model for more
than 2 states is defined. The methodology involved in determining the misclassification
probability can be explained by the formula shown in (equation 8). In order to investigate the
explanatory variables for the misclassification probability for each pair of states, logistic model
can be used. (The msm package, version 0.6.4) Probability of observing state 2 (mild cognitive
impairment) given the underlying true state as state1 (no cognitive impairment) or state 3
(dementia) is illustrated using (equations 10-11).

(exp(𝛼0 +𝛼1 𝑐ij ))

Pr(Yij = 2|Sij = 1, cij ; α) = Pr(Yij = 2|Sij = 3, cij ; α) =  1+exp(𝛼

0 +𝛼1 𝑐ij )

(8)

If the true state is normal or dementia, then the possible misclassification rate is given by
(equation 9).

1 exp(𝛼0 +𝛼1 x)

∫0

1+exp(𝛼0 +𝛼1 x)

1

dx =  α1 [ln(1 + e𝛼0 + α1) − ln(1 +  e𝛼0 )]

(9)

This is the unique feature of multi state modeling where the misclassification
probabilities can be estimated which is an added advantage of MSM.
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CHAPTER FOUR:
SIMULATION STUDIES

Study Design

Simulation study is conducted to illustrate the importance of addressing for
misclassification in multi-state Markov models by evaluating and comparing the bias in the
estimates for the disease progression Markov model with misclassification opposed to disease
progression Markov model.
Simulation setting includes n = 3 states (state1, state2 and state3) and are assumed to
follow Markov process. The sample size or number of subjects is 500 and 1000 replications are
used for both models, multi-state model with misclassification and without misclassification.
Subjects are assumed to start at any state of disease among the defined 3 stages at initial visit
𝑡𝑖0 = 0 and are observed at 12 follow up visits at equal time intervals, 𝑡𝑖𝑗 where, 𝑗 =
2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22𝑎𝑛𝑑24 months. All transitions were allowed for this
simulation study which follows the general form of multi state Markov model shown in Figure 1.
The transition intensity matrix Q is supplied with values ( 𝑞12 = 0.1, 𝑞13 = 0.01, 𝑞21 =
0.05, 𝑞23 = 0.1, 𝑞31 = 0.02, 𝑞32 = 0.07)to generate the true states of disease. The diagonal
values are ignored as each row sums to 1. The observed states are conditionally dependent on the
true states with misclassification probabilities. The misclassification probability matrix
13

considered for simulation purpose is (𝑒12 =  𝑒13 =  𝑒21 = 𝑒23 = 𝑒31 = 𝑒32 = 0.30) . A
prognostic covariate following binomial distribution is introduced with a proportion of 0.5 and
the covariate effect on the matrix of transition intensities is considered to be same for all the
transitions with a value of -0.3. Two scenarios were investigated in this study, model without
covariates and model with one prognostic covariates to investigate the effect of misclassification
on estimation of transition probabilities and on covariate effect on transition probabilities. Both
scenarios follow the same scheme except the inclusion of covariate in which a multi-state
Markov model addressing for misclassification is fit to the data and a separate multi state
Markov model is fit to the data without addressing for misclassification using the same
regression coefficients for the covariate in both models and the average of the estimated
covariate effect on the transitions from all the simulations is calculated and were compared with
the true covariate effect in order to examine the performance of both the models in order to
visualize the effect of misclassification on estimates and show that if misclassification is not
accounted while estimating the transition probabilities in multi-state models, it might lead to
bias. A very limited research has been reported on addressing misclassification issue in multistate models and proving this concept theoretically is complex, thus simulation study is used to
show the bias in estimates if misclassification has not been addressed.

Simulation Results

The results from simulation study for the scenario in which covariate is not included are
compared between misclassification model and the MSM model in Table 1. It is observed that
14

the estimated transition intensities from Multi state model fit to the simulated data without
addressing for misclassification are biased when compared to the true parameter. Results from
the model with covariate were shown in Table 2 and the results suggest that the estimates from
the model without addressing misclassification model were biased. Whereas the results from
misclassification model in both scenarios (Multi state model is fit to the simulated data
addressing misclassification) showed minimal or no bias when compared to true transition
probabilities and true covariate effects. In order to assess the performance, the results were
compared with the model without addressing for misclassification by reporting their bias from
the true parameters in Table 1 These results strongly suggest that, there is significant impact of
misclassification on estimation of the transition probabilities from one state to other state.
Therefore, multi-state model with misclassification is proved to give unbiased estimates when
compared to the multi-state model without addressing misclassification, which strengthens the
argument that if misclassification not addressed in multi-state models, leads to bias and also the
methodology proposed for addressing misclassification performs better compared to MSM
without addressing misclassification.

15

Table 1 Results from simulation study – scenario without covariates, comparing the mean estimates from the model addressing
misclassification and the model without addressing misclassification to the true transition probabilities.

True transition Model addressing misclassification Model not addressing misclassification
probability
mean estimate
Bias
mean estimate
Bias
Transitions
State 1 - State 1

0.898

0.899

0.001

0.439

-0.459

State 1 - State 2

0.045

0.043

-0.002

0.287

0.242

State 1 - State 3

0.019

0.02

0.001

0.295

0.276

State 2 - State 1

0.088

0.087

-0.001

0.302

0.214

State 2 - State 2

0.866

0.866

0.000

0.395

-0.471

State 2 - State 3

0.063

0.058

-0.005

0.306

0.243

State 3 - State 1

0.014

0.014

0.000

0.258

0.244

State 3 - State 2

0.089

0.089

0.000

0.319

0.23

State 3 - State 3

0.917

0.921

0.004

0.402

-0.515
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Table 2 Results from simulation study – scenario with covariate, comparing the mean covariate estimates from the model addressing
misclassification and the model without addressing misclassification to the true covariate coefficient.
True covariate Model addressing misclassification Model not addressing misclassification
effect (exp(β)) mean estimate
Bias
mean estimate
Bias
Transitions
State 1 - State 2

0.741

0.730

-0.011

0.763

0.022

State 1 - State 3

0.741

0.702

-0.039

0.542

-0.199

State 2 - State 1

0.741

0.605

-0.136

1.143

0.402

State 2 - State 3

0.741

0.785

0.044

1.115

0.374

State 3 - State 1

0.741

0.772

0.031

0.486

-0.255

State 3 - State 2

0.741

0.783

0.042

3.437

2.696
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CHAPTER FIVE:
ILLUSTRATION USING DEMENTIA DATA

In this study, the proposed method of accounting for misclassification using hidden
Markov models (multi state Markov model with misclassification) is illustrated using dementia
data.

Background on Dementia

Although commonly used to refer to a disease state, the term “dementia” does not refer to
a disease at all but rather a syndrome characterized by memory loss and impaired activities of
daily living (ADLs). (American Psychiatric Association, 1994) Alzheimer’s disease is a complex
neurodegenerative disease characterized by a decline in cognition, behavioral disturbance and
reductions in daily functioning and independence. Alzheimer’s disease is the most common
form of dementia, accounting for 60-80% of all cases in epidemiological studies. (Knopman DS,
1998)
Alzheimer’s disease is a progressive brain disorder that slowly destroys memory and
thinking skills and eventually, the ability to carry out the simplest tasks. In most people with
Alzheimer’s, symptoms first appear in their mid-60s. Estimates vary, but experts suggest that
18

more than 5 million Americans may have Alzheimer’s. Dementia is the loss of cognitive
functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent
that it interferes with a person’s daily life and activities. (AD fact sheet, 2015)
The classic neuropathological signs of Alzheimer’s disease are amyloid plaques and
neuro fibrillary tangles. Plaques consist largely of the protein fragment beta-amyloid. This
fragment is produced from a "parent" molecule called amyloid precursor protein. The
accumulation of neurofibrillary tangles and neuronal loss is initially observed in trans-entorhinal
and entorhinal cortex (ERC), and subsequently in the hippocampus (HPC). (Braak & Braak,
1991) Atrophy in the ERC and the hippocampus on MRI scans is also predictive of future
cognitive decline and conversion to AD among individuals with Mild Cognitive Impairment
(MCI). (Jack et al., 1999, 2000; Rusinek, 2003)
Dementia cannot be diagnosed by a single test. It is generally diagnosed based on
medical history, brain scans, physical exams, laboratory tests, characteristics changes in thinking
and behavior and impact on day to day functions. Dementia can be determined at a high level of
certainty but determining the exact stage of dementia is difficult because, the symptoms and
brain changes can overlap. (Alzheimer’s Association)
Analyzing such data in this context is very complicated and possible challenges in
screening of stages of dementia are that the subjects are observed intermittently. For example, a
healthy subject at first visit might die before his follow up visit and he might have transitioned to
intermittent disease state without diagnosis. Even the exact transition time may not be known in
most of the situations and it is also important to know the number of transitions occurred to
determine the course of disease. Thus, for this study, this data is used to illustrate the application
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of multi state model with misclassification to determine the impact of misclassification on effect
of covariates in disease progression or regression.

Data Source

Data from subjects who participated in a diagnostic study of Alzheimer’s disease is used
in this study. All subjects in this study completed subject evaluation which includes full clinical
history, neurological evaluation, neurophysiologic tests, MRI brain scan, verbal learning test and
standard blood tests. Consensus screening was performed on all the subjects by multiple
clinicians as per National Alzheimer’s coordinating center NAAC protocol. The state of disease
of subjects was determined according to national Institute of neurological and communicative
Disorders and Stroke (NINCDS), Alzheimer’s disease and Related Disorders Association
(ADRDA) criteria for AD. Subjects with no cognitive impairment, mild cognitive impairment
and dementia were included in the study. The normal subjects, participants with no cognitive
impairment were determined based on the cognitive score of informant interview, where there is
no decline in cognition. Participants reported with stroke or transient ischemic attack or any
cerebrovascular events were excluded from the study. 802 Subjects entered the study irrespective
of their state of disease at first visit. Longitudinal evaluation procedure was used where subjects
were followed and reevaluated at 1-year where 441 subjects turned out for follow up visit. Each
subject’s state of disease was recorded at their follow up visit.
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Specifying a Multi-State Markov Model

A multi-state Markov model is fit to the data using a progressive three state
disease model in which a set of states (3 stages of disease) is considered and is shown in Figure
4. It is well established that dementia is an irreversible disease which means that once if a subject
is diagnosed with mild cognitive impairment, he/she is supposed to progress to dementia and
recovery from dementia is not possible without surgical treatment. Thus, in this study transition
from MCI to no cognitive impairment stage is considered as it is referred to natural recovery but
recovery from dementia to MCI is not allowed in this study as possible transition unless it is
misclassified because without surgical treatment, dementia is theoretically not possible to revert
to lower stages of disease.

𝑆 =  [𝑠1 , 𝑠2 , 𝑠3 ]

(6)

Where,
𝑠1 = Normal or No cognitive impairment,
𝑠2 = MCI-Mild Cognitive Impairment,
𝑠3 = Dementia.

Figure 4: Dementia Progression Markov chain model
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If the subject is at state 𝑆𝑖 and advances to 𝑆𝑗 with a probability 𝑃𝑖𝑗 (Transition
probability) which is not dependent on the state in which the subject is prior to the present 𝑆𝑖
state. If the subject remains in the same state, then the transition probability is given by𝑃𝑖𝑖 . A
common initial state is not specified for this study because; the data used for this study was
collected from a diagnostic technique development study where participants enter the study
irrespective of state. The demographics of the sample collected are shown in Table 3.

Table 3: Demographics

Sample size
Age, means(std)

NCI

MCI

Dementia

258

412

132

72.65 (6.61) 75.03 (6.29) 76.53 (7.25)

Female %

69.69

52.42

52.76

Low education %

7.04

19.89

17.82

Apoe 4 %

25.48

30.53

51.85

The Markov process for this study starts in one of the states mentioned in Figure 4 and
moves successively from one state to the other. For example, if the subject is diagnosed with a
mild cognitive impairment at his first visit, then his is screened again for his state of disease
during his second visit, he might have progressed to next state of disease, reversed or recovered
to the previous no disease state or might have stayed in the same state. Absorbing state is not
included in the model. All this information is recorded for all the participants and used to
determine the frequencies of transitions between the stages of dementia and were shown in Table
4. Frequencies were reported for the participants who showed up for the follow up visit.
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It is supposed that the cognitive impairment progresses from no cognitive impairment to
Mild cognitive impairment and then progress to dementia and recovery to the adjacent previous
stage are considered possible. Accordingly, a plausible transition intensity matrix is developed
(equation 10).

Table 4 Frequencies of transitions between stages of dementia

Frequency of transitions

Initial stage

Stage 1

Stage 2

stage 3

Stage 1 No Cognitive impairment

143

18

0

Stage 2 Mild Cognitive impairment

30

176

11

Stage 3 Dementia

0

7

56

−(𝑞12 )

NCI

MCI

Dementia

Sample size

258

412

132

Age, means(std)
𝑄 = 

72.65
75.03
76.53
𝑞21 (6.61)
−(𝑞21
+ 𝑞(6.29)
𝑞23 (7.25) (10)
23 )
69.69
52.42
52.76

Female %

𝑞12

0

0
Low education %( 7.04

𝑞32
19.89

−𝑞32 )
17.82

Apoe 4 %

30.53

51.85

25.48

It indicates progression and recovery from one stage to its adjacent stage and direct
transition from no cognitive impairment to dementia or the reciprocal is not allowed as it is not
possible medically in 1 year unless there is error in diagnosis. Using this transition intensity
matrix, multistate model is fit to the data using msm package “R” This matrix is required to
specify the allowed transitions and the transitions that are not allowed are given a value of 0.
Initial values are supplied to all other possible transitions leaving the diagonal values in Q matrix
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as they are the negative value of the sum of all other transitions in that row and each row sums to
1. Then, multi-state model is fit to the data by supplying the Q matrix with allowed transitions
and appropriate initial values using msm package in R. (Jackson (2011); msm package R)

Results from Fitting Multi State Model to Dementia Data

Multi state model was fit to the data using three transition states and using apoe ε4 and
low education as covariates without addressing for misclassification. Where transition
probabilities and hazard ratios for disease progression and disease regression at one-year followup were obtained and presented in Table 6. There is no significant effect in both disease
progression and regression shown by gene Apoe ε4 and low education.
According to the results from model-1 (model without accounting for misclassification),
Apoe ε4 gene and low education do not show and significant effect on transition of disease from
no cognitive impairment (state1) to mild cognitive impairment (state 2), mild cognitive
impairment (state2) to dementia (state3) or the recovery from any state to its adjacent previous
state. Therefore, claiming that positive Apoe ε4 gene and low education does not have effect on
disease progression or disease regression

Fitting Multi State Markov Model with Misclassification

Fitting general multi state Markov model to that data might lead to biased estimates as
the screening or diagnosis of dementia states are subject to error. It should be noted that though
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the transition from dementia to lower states is not theoretically possible, there are subjects
showing transition from dementia to MCI which is possible only in case of misclassification.
Therefore, the resulting model without addressing misclassification is compared with hidden
Markov model to determine the transition misclassification rates.
As stated before, for multi-state Markov model with misclassification it is assumed that
the underlying true states follow Markov process with the matrix Q (transition intensity matrix)
and the observed disease states are assumed to depend on the corresponding underlying true
states with misclassification probability. Considering the irreversible nature of the dementia
without surgical procedures and it is also known that only in rare situations recovery is possible,
so the above mentioned model might be medically not realistic for majority of population. Thus,
it is required to fit a multi-state Markov model with misclassification (Hidden Markov model) in
order to account for misclassification. For that, the previous two intensity matrix is replaced by a
one-way transition intensity matrix (equation 11) where recovery from any state is not
considered.

𝑄 = 
(

−𝑞12

𝑞12

0

0

−𝑞23

𝑞23

0

0

(11)

0 )

It is assumed that, state 1 (no cognitive impairment could be classified as either mild
cognitive impairment or no cognitive impairment (state 1 or state 2). similarly, state 2 (mild
cognitive impairment could be classified as no cognitive impairment or dementia or mild
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cognitive impairment (state1, state2 or state3) and likewise, dementia (state 3) could be classified
as state 2 (mild cognitive impairment) or state 3. Possible observed states for each underlying
true state is depicted in Table 5 Based on these possibilities; the misclassification matrix is given
below (equation 12) where rows represent underlying states and columns represent observed
states.

Table 5: Possible observed states for each underlying state for this study

Underlying true state

Possible observed state
State 1

State 1

State 2
State 1
State 2

State 2
State 3
State 2

State 3

State 3

1 − 𝑒12

𝑒12

0

𝑒21

1 − 𝑒21 − 𝑒23

𝑒23

0

𝑒32

𝐸 = 
(

(12)

1 − 𝑒32 )

The E matrix is defined in order to model the observed states with misclassification and
the value is given as zero if there is no misclassification permitted and this is determined using
Table 5 and all other misclassification probabilities (𝑒12 , 𝑒21 , 𝑒23 𝑎𝑛𝑑𝑒32 )were given an initial
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value of 0.1. Similar to the Q matrix, the diagonal values were ignored as the rows sum to 1. A
Hidden Markov model is fit to the data along with the new Q matrix and E matrix to determine
the misclassification probabilities. It is also investigated whether the misclassification
probabilities depend on covariates by using the ‘misccovariates’ argument in msm. (Jackson
(2011); msm package R)

Results from Fitting Hidden Markov Model (Multi State Model with Misclassification) to
Dementia Data

The results from model-2 (Hidden Markov model) to dementia data are contrary to that
obtained from fitting multi state Markov model to dementia data for one of the disease
progression transition. Though estimates for remaining transitions were in line with the estimates
from model-1. Results from model-2 were shown in Table 6 which suggests that Apoe ε4 gene is
significantly associated with the disease transition from mild cognitive impairment to dementia.
There is no significant effect shown by Apoe ε4 gene for rest of the disease state transitions and
also there is no significant association shown by low education on any of the disease state
transitions related to neither disease progression or in the regression of the disease. The
misclassification probabilities for each disease transition mentioned in the Q matrix were also
estimated using this model.
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Table 6 Comparing results from fitting dementia data with progressive multi state model and Hidden Markov model (multi state
Markov model with misclassification)

HR*

Model addressing misclassification
Apoe ε4
Low education
95% CI
p-value
HR*
95% CI
p-value

HR*

Model not addressing misclassification
Apoe ε4
Low education
95% CI
p-value
HR*
95% CI
p-value

Progression of disease
NCI-MCI

1.094

(0.512-1.619)

MCI-Dementia

1.973

(1.451-1.999) <0.0001

0.772

1.732

(1.242-1.924)

0.375

1.122

(0.362-3.479)

0.101 2.43E-07

1.745

(0.469-1.986)

0.651

2.234

(0.772-6.466)

0.977

1.745

(0.469-1.987)

0.769

0.443

(0.167-1.172)

0.732

(0.101-1.724) 0.2244 4.63E-07

(0-Inf)

(0-1.428)

0.217

0.582

(0.129-2.624)

0.96

0.841

0.547

(0.208-1.427)

0.994

0.138

0.0004

(0-Inf)

0.481

Regression of disease
MCI-NCI
Dementia-MCI

0.104 (0.0001-1.967) 0.768
1.35E-07

(0 - Inf)

0.6514

*Notes: HR is the estimated hazard ratio; 95% CI is the 95% confidence interval.
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Misclassification Probabilities

Misclassification probabilities for the defined transitions in the Q matrix were estimated
and shown in Table 7. The probability of observing no disease state given the underlying true
state is no disease state is found to be 0.816, which is considered as 81.6% specificity of
classifying a subject with no cognitive impairment as disease state 1. The probability of
misclassifying Normal state as MCI is found to be 0.183(0.091, 0.334) and the probability of
misclassifying MCI as Normal is found to be 0.0157(9.25e-12, 1.0). The probability of observing
MCI given MCI state is found to be 0.984(2.24e-08, 1.0) which can be considered as sensitivity of
observing MCI as 98.4%. Similarly, the probability of observing dementia given dementia is found to be
0.997(1.42e-109, 1.0) which can also be considered as sensitivity of diagnosing dementia as 99.7%. The
probability of misclassifying MCI as dementia is found to be 0.00012((2.88e-07, 0.049) and the
probability of misclassifying Dementia as MCI is found to be 0.0028(1.12e-114, 1.0). Thus, the false
positive rate for mild cognitive impairment stage is found to be 18% and false positive rate for dementia
is found to be 0.012 %.

Table 7 Misclassification probabilities

Underlying true state

Observed state

Misclassification probability

95% CI

State 1

State 2

0.1834

(0.0914, 0.334)

State 1

0.0157

(9.25e-12, 1.0)

State 3

0.00012

(2.88e-07, 0.049)

State 2

0.0028

(1.12e-114, 1.0)

State 2
State 3
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DISCUSSION
Most of the chronic diseases have a well-known natural staging system through which the
disease progression is interpreted. It is well established that the transition rates from one stage of
disease to other stage can be modeled by multi state Markov models. But, it is also well known
that the screening systems used to diagnose disease states may subject to error some times. In
this study simulation is used to illustrate the importance of addressing for misclassification in
multi-state Markov models by evaluating and comparing the estimates for the disease
progression Markov model with misclassification opposed to disease progression Markov model.
These results from simulation study strongly suggest that the estimates from multi state model
without addressing for misclassification lead to significant bias when compared to the true
parameters and suggest better performance of multi state models with misclassification. The
application of hidden Markov model (multi state model with misclassification) to real data is
illustrated using dementia data and impact of misclassification on effect of covariates on disease
transition is evaluated.
It is well established that apoe ε4 is associated with Alzheimer’s disease but its
association with Dementia is inconsistent. (Yi-Fang Chuang et al., 2010) There was minimal
research on examining the association of apoe ε4 gene on transition of disease from one stage to
the other. A general hidden Markov model was presented for estimating transition rates and
probabilities of misclassification of stages of disease and concluded that regression of disease
can be explained by misclassification. This is because even though Markov processes were well
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established method of estimating rates of transition between each stage of disease, diagnosis of
disease stages might be subject to error. (Jackson, Christopher H., et al, 2003) Results based on
data from the Biologically Resilient Adults in Neurological Studies (BRAiNS) cohort, a
longitudinal study of aging and cognition at the University of Kentucky Alzheimer’s Disease
Center (UK ADC), demonstrated that well established risk factors for dementia (i.e., age,
education, family history of dementia, apolipoprotein ε-4 status) were also risk factors for
transitions from normal cognition to transient MCI states. (Kryscio et al, 2006, Salazar et al,
2007) In this study we examined the association of apoe ε4 in disease incidence or progression
from no cognitive impairment to mild cognitive impairment or from mild cognitive impairment
to dementia and also examined the association of apoe ε4 in disease regression from mild
cognitive impairment to no cognitive impairment after accounting for misclassification.
To test this hypothesis, data with subjects at different stages of dementia who were
followed up for 1 year was used. Multi state model with misclassification was fit to the data to
test the mentioned hypothesis. This idea is supported by other studies where the impact of
misclassification of age-related macular degeneration(AMD) on baseline intensity and estimated
effects of age, sex on incidence, progression and regression of AMD. (Ronald E. Gangnon et al,
2014) and employing hidden Markov model allowing for misclassification is well suited to
analysis of health service databases to determine the transition probabilities between two states,
and of misclassification and capture bias due to the fact that the quality and accuracy of the
available information are not always optimal. (Nicola Bartolomeo et al, 2011)
It is well established that apoe-4 protein levels contribute to the risk of Alzheimer’s
disease (Laws, Simon M., et al, 2003) and the association between apoe-4 and vascular dementia
in a large population based cohort was examined for ten years and concluded that the apoe-4
31

allele is associated with increased risk of vascular dementia in a dose dependent fashion.
(Chuang, Y-F., et al. 2010) There are several other studies which proved association of apoe-4
with Alzheimer’s disease but there is lack of evidence through studies showing effect of apoe-4
in disease progression and regression which is addressed in this study.
In this study multi state model with misclassification is used to account for the
misclassification and found that after addressing for misclassification, apoe ε4 gene explains the
disease progression from mild cognitive impairment to dementia. Apoe ε4 gene is found to have
significant association with the transition of disease state from mild cognitive impairment to
dementia which was masked when multi state model was fit to the data without addressing for
misclassification.
There is no significant association of Apoe ε4 gene found with other transitions. In this
study we also estimated if there is any association of low education with disease incidence,
progression or regression with and without addressing for misclassification and found there is no
significant association of low education. The unique ability of multi state modeling is portrayed
in a well explainable manner in this study where the methodology behind the ability of the multistate model to determine the misclassification probabilities of the disease state even in situation
where gold standard is not available. As an improvement to the general multi state modeling,
multi-state model with misclassification is fit to the data in order to address misclassification
issues in an effective method. The misclassification probability of diagnosing normal subjects as
mild cognitive impairment subjects is 18.3% and probability of misclassifying MCI subjects as
normal is 1.57% and probability of misclassifying MCI subjects as dementia patients is 0.012%
and probability of misclassifying Dementia patients as subjects with MCI is 0.28%. This proves
that misclassification of the disease state has occurred during diagnosis.
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Following up the subjects for only 1 year is one of the limitations of this study and
following up for at least 5 years is recommended in order to capture the disease transitions
involving intermittent stages. While this study focused on three state models for analysis, further
analysis is recommended by considering amnestic MCI and non-amnestic MCI to be more
specific in terms of disease transitions and also transition from dementia to MCI can be
considered if the treatment involved in recovery is included in to the model. As recovery from
dementia is being made possible due to recent advancements in treatment it could be considered
in future research. In simulation study including different rates of misclassification in increasing
fashion like 10%, 20% and 30% is recommended to determine the effect of misclassification at
different rates to study the misclassification impact in more detailed perspective.
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APPENDICES
The R code used for simulation is shown below.
#Simulation study without covariate
sim_misdf = vector("list", 1000)
test.mis = vector("list", 1000)
test_mis.msm = vector("list", 1000)
ti.mis = vector("list", 1000)
test.msm = vector("list", 1000)
ti = vector("list", 1000)
for (i in 1:1000) {
sim_misdf[[i]] <- data.frame(subject = rep(1:500, rep(13,500)), time = rep(seq(0, 24, 2), 500))
qmatrix <- rbind(c(-0.11, 0.1, 0.01 ),
c(0.05, -0.15, 0.1 ),
c(0.02, 0.07, -0.09))
ematrix <- rbind(c(0, 0.3, 0.3 ),
c(0.3, 0, 0.3 ),
c(0.3, 0.3, 0 ))
test.mis[[i]] <-simmulti.msm(sim_misdf[[i]], qmatrix,ematrix =ematrix ,death = FALSE)
Q1 <- rbind(c(1,1,1),c(1,1,1),c(1,1,1))
test_mis.msm[[i]] <- msm(obs~time,subject=subject,data=test.mis[[i]],qmatrix= Q1)
ti.mis[[i]]<- test_mis.msm[[i]]$Qmatrices
write.csv(ti.mis[[i]], file=paste0('timis', i, '.csv'), row.names=FALSE)
test.msm[[i]] <- msm(state~time,subject=subject,data=test.mis[[i]],qmatrix= Q1)
ti[[i]]<- test.msm[[i]]$Qmatrices
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write.csv(ti[[i]], file=paste0('newsim', i, '.csv'), row.names=FALSE)
}
#simulation study including covariate
sim_cov_truedf = vector("list", 1000)
cov_true = vector("list", 1000)
cov_true.msm = vector("list", 1000)
cov_true_hr = vector("list", 1000)
cov_mis.msm = vector("list", 1000)
cov_mis_hr = vector("list", 1000)
for (i in 1:1000) {
sim_cov_truedf[[i]] <- data.frame(subject = rep(1:500, rep(13,500)), time = rep(seq(0, 24, 2),
500), x=rep(rbinom(500,1,0.5),rep(13,500)))
qmatrix <- rbind(c(-0.11, 0.1, 0.01 ),
c(0.05, -0.15, 0.1 ),
c(0.02, 0.07, -0.09))
ematrix <- rbind(c(0, 0.3, 0.3 ),
c(0.3, 0, 0.3 ),
c(0.3, 0.3, 0 ))
cov_true[[i]] <-simmulti.msm(sim_cov_truedf[[i]], qmatrix,covariates=list(x = c(-0.3,-0.3,-0.3,0.3,-0.3,-0.3)),ematrix = ematrix)
Q <- rbind(c(1,1,1),c(1,1,1),c(1,1,1))
cov_true.msm[[i]] <- msm(state~time,subject=subject,data=cov_true[[i]],qmatrix= Q,covariates
= ~x, method='BFGS')
cov_true_hr[[i]] <-hazard.msm(cov_true.msm[[i]])
write.csv(cov_true_hr[[i]], file=paste0('hrcov_t', i, '.csv'), row.names=FALSE)
cov_mis.msm[[i]] <- msm(obs~time,subject=subject,data=cov_true[[i]],qmatrix= Q,covariates =
~x,method='BFGS')
cov_mis_hr[[i]] <-hazard.msm(cov_mis.msm[[i]])
write.csv(cov_mis_hr[[i]], file=paste0('hrcov_mis', i, '.csv'), row.names=FALSE)
}
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